Literature DB >> 6742743

Midazolam for upper gastrointestinal endoscopy.

P Kawar, K G Porter, E K Hunter, J McLaughlin, J W Dundee, T O Brophy.   

Abstract

A water-soluble benzodiazepine, midazolam, was used in 400 patients undergoing upper gastrointestinal endoscopy, alone or in combination with pentazocine and compared with 68 patients given diazepam (Valium). In the last 200 patients the endoscopist used midazolam without the presence of an anaesthetist. The absence of injection pain was the most notable feature of midazolam. The degree of co-operation was similar in all groups but the operating conditions were significantly better when midazolam was combined with pentazocine. There was no significant difference in recovery times between the groups as assessed by the pegboard test. Midazolam is an acceptable alternative to diazepam for upper gastrointestinal endoscopy.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6742743      PMCID: PMC2492706     

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  12 in total

1.  Estimation of plasma diazepam. Critique of a method using gas-liquid chromatography and benzene extraction.

Authors:  J A Gamble; R A Assaf; J S Mackay; M S Kennedy; P J Howard
Journal:  Anaesthesia       Date:  1975-03       Impact factor: 6.955

2.  Clinical studies of induction agents. XLIII: recovery from althesin--a comparative study with thiopentone and methohexitone.

Authors:  I W Carson; J Graham; J W Dundee
Journal:  Br J Anaesth       Date:  1975-03       Impact factor: 9.166

3.  Neuroleptanalgesia in upper alimentary endoscopy.

Authors:  H I Le Brun
Journal:  Gut       Date:  1976-08       Impact factor: 23.059

4.  Sequelae after the intravenous injection of three benzodiazepines--diazepam, lorazepam, and flunitrazepam.

Authors:  J E Hegarty; J W Dundee
Journal:  Br Med J       Date:  1977-11-26

5.  Premedication for upper gastrointestinal endoscopy: a comparative study of flunitrazepam, diazepam and neuroleptanalgesia.

Authors:  W S Nimmo; J A Forrest; R C Heading; N D Finlayson; L F Prescott
Journal:  Endoscopy       Date:  1978-08       Impact factor: 10.093

6.  Effects of doxapram on postoperative pulmonary complications following thoracotomy.

Authors:  P S Sebel; E J Kershaw; W S Rao
Journal:  Br J Anaesth       Date:  1980-01       Impact factor: 9.166

7.  Frequency of pain on injection and venous sequelae following the I.V. administration of certain anaesthetics and sedatives.

Authors:  P Kawar; J W Dundee
Journal:  Br J Anaesth       Date:  1982-09       Impact factor: 9.166

8.  Midazolam: a water-soluble benzodiazepine. Studies in volunteers.

Authors:  J W Dundee; I O Samuel; W Toner; P J Howard
Journal:  Anaesthesia       Date:  1980-05       Impact factor: 6.955

9.  Amnesic action of midazolam.

Authors:  J W Dundee; D B Wilson
Journal:  Anaesthesia       Date:  1980-05       Impact factor: 6.955

10.  Evaluation of midazolam as an intravenous induction agent.

Authors:  J A Gamble; P Kawar; J W Dundee; J Moore; L P Briggs
Journal:  Anaesthesia       Date:  1981-09       Impact factor: 6.955

View more
  5 in total

1.  A comparison of diazepam and midazolam as endoscopy premedication assessing changes in ventilation and oxygen saturation.

Authors:  G D Bell; A Morden; T Coady; J Lee; R F Logan
Journal:  Br J Clin Pharmacol       Date:  1988-11       Impact factor: 4.335

2.  Midazolam versus diazepam for combined esophogastroduodenoscopy and colonoscopy.

Authors:  D E Brouillette; R Leventhal; S Kumar; D Berman; M Kajani; Y K Yoo; J Carra; R Tarter; D H Van Thiel
Journal:  Dig Dis Sci       Date:  1989-08       Impact factor: 3.199

3.  Midazolam sedation for outpatient fibreoptic endoscopy: evaluation of alfentanil supplementation.

Authors:  K R Milligan; J P Howe; J McLoughlin; W Holmes; J W Dundee
Journal:  Ann R Coll Surg Engl       Date:  1988-09       Impact factor: 1.891

4.  Intravenous midazolam for upper gastrointestinal endoscopy: a study of 800 consecutive cases relating dose to age and sex of patient.

Authors:  G D Bell; G P Spickett; P A Reeve; A Morden; R F Logan
Journal:  Br J Clin Pharmacol       Date:  1987-02       Impact factor: 4.335

Review 5.  Midazolam. A review of its pharmacological properties and therapeutic use.

Authors:  J W Dundee; N J Halliday; K W Harper; R N Brogden
Journal:  Drugs       Date:  1984-12       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.